21三体在滤泡性淋巴瘤中的预后影响
研究对2001至2013年间201例滤泡性淋巴瘤患者进行诊断时G显带染色体分析,评估染色体异常模式与临床结局的关系。结果发现21三体患者无进展生存期(P=0.00171)和总生存期(P<0.001)显著缩短,在利妥昔单抗治疗队列中总生存期也显著缩短(P=0.000428)。多因素分析显示21三体是独立危险因素(P=0.015)。
要点
- 21三体患者无进展生存期显著缩短(P=0.00171)
- 21三体患者总生存期显著缩短(P<0.001)
- 多因素分析显示21三体是独立危险因素(P=0.015)
核心结论
- 21三体的存在是滤泡性淋巴瘤的独立危险因素。
- 诊断时对滤泡性淋巴瘤患者进行染色体分析可提供预期生存信息。
研究设计与样本
- 采用诊断时标准G显带方法对2001至2013年间收治的201例滤泡性淋巴瘤患者进行染色体分析。
主要发现
- 检出的染色体异常包括:t(14;18)(q32;q21)(59.2%)、+X(17.9%)、del(6)(q)/-6(16.9%)、+7(14.4%)、1q12-21/1q异常(12.9%)、del(13)(q)/-13(11.9%)、3q27异常(10.4%)、10q22-24异常(10.0%)、+12/dup(12)(q)(10.0%)、1p21-22/1p异常(9.0%)、+18(9.0%)、del(17)(p)/-17(5.0%)及复杂核型(54.7%)。
- 21三体患者较无21三体患者无进展生存期显著缩短(P=0.00171),总生存期显著缩短(P<0.001)。
- 在利妥昔单抗治疗队列中,21三体患者总生存期也显著缩短(P=0.000428)。
- 多因素分析显示,在伴或不伴t(14;18)的队列中,21三体均为独立危险因素(P=0.015)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The chromosomal abnormalities associated with follicular lymphoma (FL) prognosis are not fully elucidated. Here, we evaluated the pattern of chromosomal abnormalities in FL, and clarified the correlations between the cytogenetic features and clinical outcome. Cytogenetic analysis was performed using standard methods of Giemsa-banding at diagnosis for 201 FL patients admitted to our hospitals between 2001 and 2013. The identified chromosomal abnormalities were: t(14;18)(q32;q21) (59·2%), +X (17·9%), del(6)(q)/-6 (16·9%), +7 (14·4%), abnormality of 1q12-21/1q (12·9%), del(13)(q)/-13 (11·9%), abnormality of 3q27 (10·4%), abnormality of 10q22-24 (10·0%), +12/dup(12)(q) (10·0%), abnormality of 1p21-22/1p (9·0%), +18 (9·0%), del(17)(p)/-17 (5·0%), and a complex karyotype (54·7%). Patients with trisomy 21 had a significantly shorter progression-free survival (P = 0·00171) and overall survival (OS) (P < 0·001) than those without trisomy 21; additionally, patients with trisomy 21 in the rituximab-treated cohort also had a significantly shorter OS (P = 0·000428). Multivariate analysis identified trisomy 21 as an independent risk factor in our cohorts with or without t(14;18) (P = 0·015). In conclusion, the presence of trisomy 21 was an independent risk factor for in FL. Chromosomal analysis of FL patients at diagnosis can provide useful information about their expected survival.
引用
- Mitsui T, Yokohama A, Koiso H, et al. Prognostic impact of trisomy 21 in follicular lymphoma. Br J Haematol. 2018. PMID: 30417943. doi:10.1111/bjh.15664
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。